Gemnil 200 mg and 1000 mg powder for infusion – gemcitabine for cancer treatment
Pogledajte blok ispod gde možete pronaći proizvode koji su slični ili imaju slična dejstva kao proizvod na čijoj se stranici nalazite.
- Stock: Zabrana online prodaje
- Brand: VIANEX S.A.
- Model: BR-1556855410
Gemnil contains gemcitabine, a cytotoxic medicine from the group of pyrimidine analogues. Cytotoxic medicines kill dividing cells, including cancer cells. Gemnil is given alone or in combination with other anticancer medicines, depending on the type of cancer.
In Serbia it is authorised as Gemnil powder for solution for infusion in two strengths – a vial with 200 mg and a vial with 1000 mg gemcitabine (manufacturer Vianex S.A., Greece; marketing authorisation holder Beocompass d.o.o. Beograd). The medicine is given only in a healthcare institution as an intravenous infusion.
Important warning
- Prescription status in Serbia: for use in inpatient healthcare institutions only (SZ); prescribed by an oncologist experienced in chemotherapy.
- The blood count is checked before every infusion, and liver and kidney function periodically – the dose may be reduced or treatment delayed.
- The medicine must not be used during breast-feeding; pregnancy should be avoided, and men are advised not to father a child during treatment and for 6 months afterwards.
- This page is for information only and is not an offer to buy the medicine online.
What is Gemnil (gemcitabine) used for and how is it given?
Key facts about the medicine
| Medicine name | Gemnil, 200 mg and 1000 mg, powder for solution for infusion |
|---|---|
| Active substance | gemcitabine (as gemcitabine hydrochloride) |
| Strength | 200 mg or 1000 mg gemcitabine per vial; 38 mg/mL after reconstitution |
| Pharmaceutical form | powder for solution for infusion (white to off-white lyophilised powder) |
| Therapeutic group | antineoplastic agents – pyrimidine analogues (ATC L01BC05) |
| Pack | 1 glass vial (1 x 200 mg or 1 x 1000 mg) |
| Marketing authorisation holder / manufacturer | BEOCOMPASS DOO BEOGRAD; manufacturer VIANEX S.A. – PLANT C', Pallini, Attiki, Greece |
| ALIMS authorisation number | 200 mg: 515-01-02404-21-001; 1000 mg: 515-01-02405-21-001 – both of 23 May 2022 |
| Prescription status (Serbia) | SZ – for use in inpatient healthcare institutions only |
What is Gemnil used for?
According to the leaflet and the SmPC, gemcitabine is used to treat:
- non-small cell lung cancer (locally advanced or metastatic) – first line in combination with cisplatin, and alone in elderly patients or patients with performance status 2;
- pancreatic cancer (locally advanced or metastatic adenocarcinoma);
- breast cancer – in combination with paclitaxel, in relapse after adjuvant/neoadjuvant chemotherapy;
- ovarian cancer (epithelial) – in combination with carboplatin, in relapse at least 6 months after first-line platinum-based therapy;
- bladder cancer – in combination with cisplatin.
How is it given and dosed?
The medicine is prepared by the hospital pharmacist or doctor and given intravenously as an infusion lasting about 30 minutes. The usual dose is 1000–1250 mg per square metre of body surface area, calculated from height and weight. The schedule depends on the type of cancer (according to the SmPC):
| Indication | Dose and schedule |
|---|---|
| Bladder cancer | 1000 mg/m² on days 1, 8 and 15 of a 28-day cycle, with cisplatin |
| Pancreatic cancer | 1000 mg/m² once weekly for up to 7 weeks, then one week rest; then once weekly for 3 weeks followed by one week rest |
| Non-small cell lung cancer – alone | 1000 mg/m² once weekly for 3 weeks, then one week rest (4-week cycle) |
| Non-small cell lung cancer – with cisplatin | 1250 mg/m² on days 1 and 8 of a 21-day cycle |
| Breast cancer – with paclitaxel | 1250 mg/m² on days 1 and 8 of a 21-day cycle |
| Ovarian cancer – with carboplatin | 1000 mg/m² on days 1 and 8 of a 21-day cycle |
- Granulocyte and platelet counts are checked before each dose; the dose is reduced or treatment delayed according to the blood count and general condition.
- If the infusion leaks outside the vein, it is stopped immediately and restarted in another vein.
Special patient groups
- Children and adolescents: not recommended under 18 years because of insufficient data on safety and efficacy.
- Older people (over 65): gemcitabine is well tolerated; no dose adjustment is needed beyond that recommended for all patients.
- Liver or kidney impairment: caution is needed because of limited data; function is checked periodically.
Contraindications – when the medicine must not be used
Gemnil must not be given:
- if you are allergic to gemcitabine or any of the excipients;
- if you are breast-feeding.
Warnings and precautions
Tell your doctor, nurse or hospital pharmacist before treatment:
- if you have or have had liver, heart or blood vessel disease, or lung or kidney problems;
- if you have recently had or are due to have radiotherapy – an early or late radiation reaction is possible;
- if you have recently been vaccinated, especially against yellow fever;
- if headache with confusion, seizures or vision changes occur during treatment (posterior reversible encephalopathy syndrome – very rare);
- if you feel short of breath, weak or very pale (possible signs of kidney or lung problems);
- if you notice generalised swelling, shortness of breath and weight gain (capillary leak syndrome).
The medicine is essentially "sodium-free" (less than 1 mmol per vial).
Interactions with other medicines
Tell your doctor about all medicines you take, including non-prescription ones. According to the SmPC:
- radiotherapy – gemcitabine increases sensitivity to radiation; concurrent use (7 days apart or less) can cause severe toxicity (e.g. oesophagitis, pneumonitis), so the oncologist decides the schedule;
- yellow fever vaccine and other live attenuated vaccines – not recommended because of the risk of severe systemic disease.
Pregnancy and breast-feeding
- Pregnancy: use should be avoided; women are advised to avoid pregnancy during treatment and to tell the doctor immediately if it occurs.
- Breast-feeding: breast-feeding must be stopped during treatment.
- Fertility: men are advised not to father a child during treatment and for up to 6 months afterwards; advice on sperm storage can be sought before treatment.
Driving and using machines
Gemnil can cause drowsiness, especially with alcohol. Do not drive or operate machines until you are sure that you do not feel drowsy.
Possible side effects
Tell your doctor immediately about: bleeding (gums, nose, mouth) or unexplained bruising, reddish urine, a temperature of 38 °C or more and signs of infection, marked tiredness and paleness, mouth sores, irregular heartbeat, breathing difficulties, severe chest pain, a severe allergic reaction, generalised swelling or a severe blistering rash.
According to the leaflet, the following may occur:
- very common (more than 1 in 10): low white blood cell count, anaemia, shortness of breath, nausea, vomiting, hair loss, abnormal liver tests, blood and protein in urine, flu-like symptoms, swelling;
- common (up to 1 in 10): febrile neutropenia, loss of appetite, headache, insomnia, drowsiness, cough, runny nose, constipation, diarrhoea, mouth sores, itching, sweating, muscle and back pain, fever, infections;
- uncommon (up to 1 in 100): interstitial pneumonitis, heart failure, kidney failure, haemolytic uraemic syndrome, severe liver damage, stroke;
- rare and very rare: low blood pressure, severe skin blistering, reaction in previously irradiated skin, pulmonary oedema, gangrene of fingers or toes, ischaemic colitis, thrombotic microangiopathy; frequency not known: sepsis, pseudocellulitis.
Overdose and missed dose
- Overdose: no antidote is known; as the medicine is given in hospital, overdose is unlikely. If suspected, the doctor checks the blood count and gives supportive treatment if needed.
- Missed dose: attend your scheduled treatments and check-ups; if you miss an appointment, contact your doctor straight away.
When to seek medical help immediately?
- a temperature of 38 °C or higher, chills or other signs of infection;
- bleeding that does not stop, bruising, reddish urine, pinpoint bleeding in the skin;
- severe shortness of breath, chest pain, irregular heartbeat;
- reduced or no urine with marked tiredness;
- swelling of the face, lips or throat, a severe blistering rash;
- headache with confusion, seizures or vision changes.
Pharmacist's advice
Between cycles keep a note of your temperature and symptoms and attend blood count checks – a raised temperature with a low white cell count needs urgent contact with the oncology team. Ask your oncologist before any vaccination, especially against yellow fever.
Flu-like symptoms and tiredness are common after the infusion. Ask your oncologist or hospital pharmacist before taking any non-prescription medicine or food supplement.
Availability and price
Gemnil is used only in inpatient healthcare institutions and is not dispensed in community pharmacies. This page is purely informative and is not an offer to sell the medicine online.
You will receive all information about your treatment from your oncologist and the institution where you are treated.
Related information
We do not list related commercial products or categories for Gemnil: it is an oncology medicine used only in hospital. Ask your oncologist before using any food supplement during chemotherapy.
Composition, pack and manufacturer
- Active substance: gemcitabine hydrochloride – 200 mg or 1000 mg gemcitabine per vial; after reconstitution the solution contains 38 mg/mL.
- Excipients: mannitol (E421), sodium acetate (E262), hydrochloric acid (E507) and sodium hydroxide (E524) for pH adjustment.
- Pack: type I glass vial with rubber stopper, aluminium cap and flip-off lid, in a protective sleeve, in a carton (1 vial).
- Marketing authorisation holder: Beocompass d.o.o. Beograd, Zvečanska 60/22. Manufacturer: Vianex S.A. – Plant C', Greece.
Storage
- The medicine does not require any special temperature storage conditions.
- The reconstituted solution is stable for 24 hours below 25 °C but, microbiologically, should be used immediately; do not refrigerate it (crystallisation may occur).
- Keep out of the sight and reach of children.
Frequently asked questions
How long does a Gemnil infusion take?
The infusion takes about 30 minutes. How often it is given depends on the type of cancer – for example once weekly for three weeks followed by a week of rest, or on days 1 and 8 of a 21-day cycle.
Why is a blood test done before each infusion?
Gemcitabine often lowers white blood cell and platelet counts. The doctor therefore checks the blood count before each dose and, if needed, reduces the dose or delays treatment.
Can Gemnil be given with radiotherapy?
Gemcitabine increases sensitivity to radiation. Concurrent use (7 days apart or less) can lead to severe toxicity, so the oncologist decides the timing of chemotherapy and radiotherapy.
What is the difference between Gemnil 200 mg and 1000 mg?
Both vials contain the same medicine; only the amount of gemcitabine differs. The dose is calculated by body surface area, and the hospital pharmacy combines vials to prepare the exact dose.
Sources
- ALIMS – Summary of Product Characteristics, Gemnil 200 mg and 1000 mg (SmPC, Serbian, 200 mg authorisation)
- ALIMS – Package leaflet, Gemnil (PIL, Serbian, 200 mg authorisation)
- ALIMS – Summary of Product Characteristics, Gemnil (SmPC, Serbian, 1000 mg authorisation)
- ALIMS – Package leaflet, Gemnil (PIL, Serbian, 1000 mg authorisation)
Sources checked on: 25 October 2026.
Pharmacy Online has a contract with the Daily Express courier service and it is delivered on the territory of the Republic of Serbia through this service. Exports of goods to foreign countries are done through DHL and PostExport.
For all orders received up to 12h from Monday to Friday, the approximate delivery time is 2-4 business days for the whole territory of the Republic of Serbia. In case the order is placed on weekends (Saturdays and Sundays), the delivery is done as well as for the orders received on Monday - so next business day.
Deliveries are not made on Saturdays and Sundays.
Additional information
The items will be packed so that they cannot be damaged by normal handling of the goods in transit. When picking up the product, the buyer is obliged to check for any damage and immediately advertise it to the courier who delivered the goods, or refuse to take over the shipment, which shows the external damage. Any subsequent product claims for shipping damage will not be considered.
When picking up the product, the customer is required to sign the delivery note taken by the Daily Express delivery worker. The delivery note is considered to be a receipt and delivery note.
The courier service delivers the goods to the address, ie. does not bring into the living space.
Delivery restrictions on goods
Delivery of items purchased on the site www.apotekaonline.rs is made exclusively through the Daily Express courier service in the territory of the Republic of Serbia. Delivery outside the territory of the Republic of Serbia, ie export of goods, is done exclusively through the service of DHL and PostExport Post of Serbia.
Shipping cost
For the territory of the Republic of Serbia:
For goods ordered up to 5.000,00 RSD, delivery charge is 350.00 RSD (VAT included). For goods over 5.000,00 RSD, shipping is free of charge.
For international delivery:
For the export of goods abroad through the PostExport service of Post of Serbia, the shipping price is for:
- Zone I (Slovenia, Croatia, Bosnia and Herzegovina, Montenegro, Northern Macedonia) - 1,280.00 RSD
- Zone II (Other European countries) - 1,790.00 RSD
- Zone III (Asia, Africa, America, Australia and other countries) - 2,650.00 RSD
Delivery time is 15 days or more (depending on the country of delivery)
For export of goods abroad through DHL service, the shipping price is 2,700.00 RSD. Delivery time is 1-5 business days (depending on the country of delivery)
Shipping cost is with tax. The price includes the delivery of the parcel to the buyer's address with the associated tax and customs at the seller's expense. A possible additional cost may be a customs charge against the buyer, depending on the country to which the package is being shipped.
For any additional questions, complaints or checking the current location of your shipment, please contact us at the following e-mail address: info@apotekaonline.rs